ArticleCells2026
Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface.
Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune checkpoint blockade (ICB) has revolutionized melanoma treatment, yet the in vivo ultrastructural consequences within the tumor microenvironment (TME) remain poorly characterized. This study investigates the morphological alterations induced by ICB at the peritumoral interface through a "redox storm" paradigm. B16F10 melanoma-bearing mice were treated with anti-CTLA-4, anti-PD-1, or their combination, and evaluated by transmission electron microscopy (TEM) at Days 20, 30, and 40; quantitative morphometric analyses were performed for comparative purposes. This design enabled the assessment of ultrastructural changes from initial immune activation to late-stage remodeling, linking early cytotoxic events with subsequent stromal adaptations. TEM provided evidence of a sequential redox cascade characterized by lymphocyte reactivation, mitochondrial cristolysis, lipid droplet accumulation, foamy macrophage-like cells, efferocytosis-driven M2-like polarization, and metabolic plasticity in surviving tumor cells. Specifically, combination therapy was associated with marked cytolysis and extensive stromal remodeling, while anti-PD-1 appeared to promote prominent cholesterol crystal formation and lipotoxicity. Morphometric analyses supported these qualitative findings, indicating significant alterations in lipid droplet area and cell death area across treatment groups. This ultrastructural dissection provides morphological evidence for the "redox storm" and offers a framework to understand ICB efficacy, resistance, and dynamic TME remodeling, ultimately providing a basis for targeted combination strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.